Healthcare Costs & Access

Health-care pricing, access, provider rules, and delivery-system reform not specific to a program.

116 events unlock with a free account

39 grant announcements77 rulemakings this week

Create free account →

July 2026

Press releases

Press release · Department of Labor · Jul 22DOL

US Department of Labor proposes rule to modernize electronic delivery for group health plans, lowering costs

Rulemaking

Comment period closing · Food and Drug Administration · Jul 22FDAClosed

Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List

Notice · Environmental Protection Agency · Jul 22EPA

AR-226-0022 - Addendum Epidemiology Protocol: An Epidemiologic Analysis of the Inpatient and Outpatient Claims Event and Episode Experience of 3M Decatur Employees, 1993-1998

Notice · U.S. Fish and Wildlife Service · Jul 22FWS

Applicant: James Badman, Mesa, AZ; Permit No. PER33159692

Notice · U.S. Fish and Wildlife Service · Jul 22FWS

Applicant: Nicholas Austin Hardin, Houston, TX; Permit No. PER33006943

Notice · U.S. Fish and Wildlife Service · Jul 22FWS

Applicant: Mathew Olsen, Victoria, TX; Permit No. PER33005203

Notice · Food and Drug Administration · Jul 22FDA

Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Rasuvo (Methotrexate) Solution, 27.5 Milligrams/0.55 Milliliter (27.5 Milligrams/0.55 Milliliter)

Notice · Food and Drug Administration · Jul 22FDA

Agency Information Collection Activities; Proposals, Submissions, and Approvals: Premarket Notifications Submission

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_021254 - Draft Guidance on Fluticasone Propionate; Salmeterol Xinafoate

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_021527 - Draft Guidance on Ipratropium Bromide

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_203214 - Draft Guidance on Tofacitinib Citrate

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_205739 - Draft Guidance on Patiromer Sorbitex Calcium

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_022518 - Draft Guidance on Formoterol Fumarate; Mometasone Furoate

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_021395 - Draft Guidance on Tiotropium Bromide

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_210115 - Draft Guidance on Tacrolimus

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_009218-Sol - Draft Guidance on Warfarin Sodium

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_021433 - Draft Guidance on Fluticasone Propionate

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_212801 - Draft Guidance on Osilodrostat Phosphate

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_019561 - Draft Guidance on Potassium Chloride

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_022008 - Draft Guidance on Ropinirole Hydrochloride

Upcoming deadlines

Bulk Drug Substances That Can Be Used To Compound Drug Products in Accordance With Section 503B of the Federal Food, Drug, and Cosmetic Act; Establishment of a Public Docket

FDA · Comment closes · Feb 22

Bulk Drug Substances That Can Be Used To Compound Drug Products in Accordance With Section 503A of the Federal Food, Drug, and Cosmetic Act; Establishment of a Public Docket

FDA · Comment closes · Feb 22

56–57 of 57

Browse the document archive